BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11513545)

  • 1. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
    Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
    Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
    Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J
    J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain.
    Yui K; Bhandoola A; Radic MZ; Komori S; Katsumata M; Greene MI
    Eur J Immunol; 1992 Jul; 22(7):1693-700. PubMed ID: 1385574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
    Giese T; Davidson WF
    J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
    Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
    J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
    Sneller MC; Straus SE; Jaffe ES; Jaffe JS; Fleisher TA; Stetler-Stevenson M; Strober W
    J Clin Invest; 1992 Aug; 90(2):334-41. PubMed ID: 1386609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of the T cell receptor repertoire in Lpr mice.
    Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL
    J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.
    Shirai T; Abe M; Yagita H; Okumura K; Morse HC; Davidson WF
    J Immunol; 1990 May; 144(10):3756-61. PubMed ID: 1970592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell activation induces the expression of a novel CD45 isoform that is analogous to murine B220 and is associated with altered O-glycan synthesis and onset of apoptosis.
    Bleesing JJ; Morrow MR; Uzel G; Fleisher TA
    Cell Immunol; 2001 Oct; 213(1):72-81. PubMed ID: 11747358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.
    Mixter PF; Russell JQ; Morrissette GJ; Charland C; Aleman-Hoey D; Budd RC
    J Immunol; 1999 May; 162(10):5747-56. PubMed ID: 10229807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver.
    Seki S; Abo T; Ohteki T; Sugiura K; Kumagai K
    J Immunol; 1991 Aug; 147(4):1214-21. PubMed ID: 1831220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of the population of double negative CD4-8- T alpha beta-cells in the liver is a common feature of autoimmune mice.
    Masuda T; Ohteki T; Abo T; Seki S; Nose S; Nagura H; Kumagai K
    J Immunol; 1991 Nov; 147(9):2907-12. PubMed ID: 1833460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.